AstraZeneca PLC

AZN

GB0009895292

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

12:15pm - American Thoracic Society Conference - Abstarct Number - P595

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

153.7 USD

Average target price

168.1 USD

Spread / Average Target

+9.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+16.64%	238B
ELI LILLY AND COMPANY	+37.89%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.63%	364B
MERCK & CO., INC.	+20.19%	332B
ABBVIE INC.	+5.08%	291B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+8.68%	169B
PFIZER, INC.	-1.62%	162B

Other Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:08 2024-05-21 am EDT			5-day change	1st Jan Change
12,364 ^GBX	+2.22%		+0.96%	+16.64%

06:18pm	European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030	MT
06:06pm	London dips as eyes turn to UK inflation reading	AN

European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030	12:18pm	MT
London dips as eyes turn to UK inflation reading	12:06pm	AN
London's FTSE 100 closes at one week-low ahead of CPI data	12:01pm	RE
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	11:12am	MT
Sector Update: Health Care Stocks Steady Premarket Tuesday	09:22am	MT
News Highlights : Top Company News of the Day - Tuesday at 9 AM ET	09:16am	DJ
AstraZeneca says building China supply chain amid US-China tensions	08:50am	RE
AstraZeneca aims for $80 bln in total revenue by 2030	07:57am	RE
News Highlights : Top Company News of the Day - Tuesday at 7 AM ET	07:18am	DJ
Stocks fall but pound up as IMF ups UK forecast	07:05am	AN
Stocks fall but pound up as IMF ups UK forecast	07:02am	AN
London stocks open lower amid Fed's cautious stance	05:13am
ASTRAZENECA : Receives a Sell rating from UBS	04:56am	ZD
AstraZeneca Targets $80 Billion Revenue by 2030, Expects to Launch 20 New Medicines	04:27am	MT
FTSE 100 declines after Asian stocks fall	04:04am	AN
AstraZeneca aims to deliver $80 billion in total revenue by 2030	03:51am	RE
AstraZeneca aims to almost double sales by 2030	03:49am	CF
AstraZeneca eyes new era of growth with bold new revenue aim	03:20am	AN
London stocks slip as Fed's cautious stance weighs on sentiment	03:18am	RE
AstraZeneca Targets $80 Billion Revenue by 2030	02:56am	MT
AstraZeneca plots "new era of growth"; SSP confident	02:54am	AN
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion	02:34am	DJ
AstraZeneca aims for $80 bln in total revenue by 2030	02:18am	RE
European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	May. 20	MT
European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices	May. 20	MT